drugset / Trial / NCT04239755

Doxycycline in Acute Traumatic Brain Injury

NCT04239755

Phase 4 Completed 50 enrolled Damanhour University Tanta University · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

evaluate the impact of Doxycycline on both clinical outcome and blood levels of NSE in patients with TBI.

Timeline

Start
2020-02-01
Primary completion
2020-07-30
Completion
2020-10-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Doxycycline Small molecule 100 mg Oral